Real-life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1-year follow-up data report.
Vinod MettaK Ray ChaudhuriValentina LetaKandadai Rukmini MridulaChaitanya KoduriSai DeepakRakesh KalpalaNageswar ReddyGuy Chung-FayeRupam BorgohainPublished in: Brain and behavior (2022)
IJLI led to persistent beneficial effects on motor and some nonmotor aspects in patients with PSP-P at up to 12 months after treatment with associated improvement in overall renal function.